| Literature DB >> 33553800 |
Pamela Marinelli Barros1, Caio Sain Vallio1, Gabriela Martins de Oliveira1, Gisela C Miyamoto1, Luiz Hespanhol1,2,3.
Abstract
BACKGROUND: Running is one of the most popular and accessible physical activities in the world. However, running-related injuries are unfortunately very common. Scientific evidence is limited and scarce regarding (cost-)effectiveness and implementation process of interventions for running-related injuries prevention. Thus, the objective of this study will be to investigate the effectiveness, cost-effectiveness and implementation process of a running-related injury prevention program (RunIn3).Entities:
Keywords: Bayesian analysis; Economic evaluation; Health behavior; Implementation science; Running; Sports injuries
Year: 2021 PMID: 33553800 PMCID: PMC7859311 DOI: 10.1016/j.conctc.2021.100726
Source DB: PubMed Journal: Contemp Clin Trials Commun ISSN: 2451-8654
Fig. 1Process overview of the study design.
Detailed part 2 interventions.
| Intervention | Mode of delivery |
|---|---|
| (1) Biweekly progression of running exposure: importance, translation of scientific evidence into practice and how to implement | text and infographic |
| (2) Importance of warm-up and stretching exercises and translation of scientific evidence into practice | text |
| (3) How to perform warming-up exercises | text and video |
| (4) Differentiation of symptoms: inflammation | text |
| (5) Differentiation of symptoms: delayed onset muscle soreness | text |
| (6) Foot strike patterns: rearfoot, midfoot and forefoot | text |
| (7) Running shoes: pronation, neutral, supination, maximalist, minimalist and conventional shoes | text |
| (8) Conditioning exercises: importance and translation of scientific evidence into practice | text |
| (9) How to perform conditioning exercises | text and video |
Outcome measures.
| This questionnaire is composed of the Brazilian-Portuguese version of the Oslo Sports Trauma Research Centre Questionnaire on Health Problems (OSTRC-BR) [ |
| (1) Running frequency (total running sessions during the 2-week period) |
| (2) Running distance (total kilometers run during the 2-week period) |
| (3) Running duration (total minutes run during the 2-week period) |
| (4) Running intensity (average perceived effort of running during the 2-week period) |
| (5) Participation in running events (i.e., races) |
| (6) Number of running events |
| (7) Total time spent on running events during the 2-week period (minutes) |
| (8) Total distance on running events during the 2-week period (kilometers) |
| (7) Running intensity during running events (average perceived effort of running during running events in the 2-week period) |
| The full questionnaire is available in |
|
|
| The preventive behavior questions are based on the Integrated Behavior Model which is composed of five determinants: intention to perform the behavior; knowledge and skills to perform behavior; attitude; subjective norm; and perceived behavioral control. Intention reflects the motivational factors influencing the behavior [ |
| (1) ‘ |
| (2) 7-point Likert agreement scale from −3 (completely disagree) to +3 (completely agree) regarding the following statement: ‘ |
| (3) ‘ |
| (4) ‘ |
| (5) Likert scale from −3 (very difficult) to +3 (very easy) regarding the following question: ‘ |
| (6) Likert scale from −3 (very difficult) to +3 (very easy) regarding the following question: ‘ |
| (7) Likert scale from −3 (no, I don't) to +3 (yes, I do) regarding the following question: ‘ |
| (8) ‘ |
| (9) ‘ |
| (10) Likert scale from −3 (not supportive at all) to +3 (very supportive) regarding the following question: ‘ |
| (11) ‘ |
| *Questions 3, 4, 8 and 9 are multiple choice questions presenting the RunIn3 components as answer options, that are: |
Feedback; |
Biweekly progression of running exposure; |
Warming-up and stretching; |
Differentiation of symptoms; |
Foot strike patterns; |
Running footwear; |
Conditioning exercises; |
None; |
I did not receive any information material. |
|
|
| The economic evaluation will be performed from a societal perspective with a time horizon of 12 months. An economic evaluation questionnaire aimed at measuring healthcare utilization costs, patient/family costs (out-of-pocket costs, complementary costs, and over the counter medication), and lost productivity costs (work absenteeism). The economic evaluation questionnaire is composed of questions about the utilization of health resources such as medication, physical therapy or medical treatment (number of sessions or visits), emergency and hospitalization services (number of visits), surgery and diagnostic tests. Furthermore, information about work absenteeism (per hour) will be collected. The questionnaire is available in |
Time-point measurements and content delivery of the RunIn3 running-related injury prevention program.
| Content | Comparison Group | Intervention Group | Time point (Week) |
|---|---|---|---|
| Baseline and monitoring questionnaire 1 | • | • | 1 |
| • | 2 | ||
| Monitoring questionnaire 2 | • | • | 3 |
| • | 4 | ||
| Monitoring questionnaire 3 and behavior questionnaire 1 | • | • | 5 |
| • | 6 | ||
| Monitoring questionnaire 4 | • | • | 7 |
| Cost questionnaire 1 | • | • | 8 |
| Monitoring questionnaire 5 | • | • | 9 |
| • | 10 | ||
| Monitoring questionnaire 6 | • | • | 11 |
| • | 12 | ||
| Monitoring questionnaire 7 | • | • | 13 |
| Cost questionnaire 2 | • | • | 14 |
| Monitoring questionnaire 8 and behavior questionnaire 2 | • | • | 15 |
| • | 16 | ||
| Monitoring questionnaire 9 | • | • | 17 |
| • | 18 | ||
| Monitoring questionnaire 10 | • | • | 19 |
| Cost questionnaire 3 | • | • | 20 |
| Monitoring questionnaire 11 | • | • | 21 |
| • | 22 | ||
| Monitoring questionnaire 12 | • | • | 23 |
| • | 24 | ||
| Monitoring questionnaire 13 | • | • | 25 |
| Cost questionnaire 4 | • | • | 26 |
| Monitoring questionnaire 14 and behavior questionnaire 3 | • | • | 27 |
| • | 28 | ||
| Monitoring questionnaire 15 | • | • | 29 |
| • | 30 | ||
| Monitoring questionnaire 16 | • | • | 31 |
| Cost questionnaire 5 | • | • | 32 |
| Monitoring questionnaire 17 | • | • | 33 |
| • | 34 | ||
| Monitoring questionnaire 18 | • | • | 35 |
| • | 36 | ||
| Monitoring questionnaire 19 | • | • | 37 |
| Cost questionnaire 6 | • | • | 38 |
| Monitoring questionnaire 20 | • | • | 39 |
| • | 40 | ||
| Monitoring questionnaire 21 | • | • | 41 |
| • | 42 | ||
| Monitoring questionnaire 22 | • | • | 43 |
| Cost questionnaire 7 | • | • | 44 |
| Monitoring questionnaire 23 | • | • | 45 |
| • | 46 | ||
| Monitoring questionnaire 24 | • | • | 47 |
| • | 48 | ||
| Monitoring questionnaire 25 | • | • | 49 |
| Cost questionnaire 8 | • | • | 50 |
| Monitoring questionnaire 26 and behavior questionnaire 4 | • | • | 51 |
| The end of the follow-up | • | • | 52 |
The ‘monitoring questionnaire’ is composed of the running-related injury and running exposure follow-up questionnaires.
DOMS: delayed onset muscle soreness.
Statistical analysis plan.
| This outcome will be established by a time-dependent dichotomous variable indicating those runners reporting RRI in each biweekly measurement. This longitudinal approach allows for runners changing their RRI status over time, that is: (1) runners can remain injury-free during the entire follow-up; (2) runners can get injured and remain injured until the end of the study; (3) runners can get injured, recover and return to the ‘no RRI’ status, and remain there until the end of the study; or (4) runners can transit multiple times between the ‘RRI’ and ‘no RRI’ strata. Therefore, the main effectiveness analysis will be performed using linear probability mixed models in order to allow outcome changes over time and to yield the absolute risk reduction (ARR) estimate between-groups [ |
|
|
| For question 1 answers of the preventive behavior questionnaire, the data processing will be performed in two steps: (1) two researchers will independently categorize the terms written by the participants into codes; and (2) two researchers will have a discussion to categorize the codes. In case of disagreements, a third researcher will adjudicate and suggest a consensus. The R Qualitative Data Analysis (RQDA) package will be used to assist in the transcriptions, coding and categorization performed in the qualitative analysis [ |
| Besides appropriateness and adherence assessed by the ‘preventive behavior and implementation’ questionnaire, penetration, adoption, fidelity and implementation costs will also be analyzed [ |
| The cost-effectiveness analysis will be performed from a societal perspective. Therefore, the total societal cost (i.e. healthcare utilization, patient/family care, lost productivity and implementation costs) will be considered. The main outcome of the economic evaluation analysis will be the incremental cost-effectiveness ratio (ICER), taking the between-group difference in total societal cost divided by the between-group difference in RRI proportion (ARR). Missing data in costs will be handled by generating 10 datasets with imputed data using the Multiple Imputation by Chained Equations (MICE) procedure. The imputation model will include age, sex, body mass index, level of education, running experience, previous RRI, running exposure data, the available costs data and all available effect measure values. The results of the 10 imputed datasets will be pooled following the Rubin's rules [ |